Our results showed that repeated I3C treatment selectively prevented the CSDS-induced depression- but not anxiety-like behaviors in mice, with an attenuation of neuroinflammation and oxido-nitrosative stress as well as an increase in BDNF levels in the brain. This evidence concerns the gene BDNF and depressive symptom measurement.